SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kidl who wrote (48721)12/1/2018 5:57:14 PM
From: ciao888  Read Replies (1) of 49402
 
Ceapro (CZO)

This stock was hyped on BNN in early to mid 2016 which took it to over $2. Since then it has dropped significantly and is at the .40 range.

Ceapro is biopharm company which sells 2 active ingredients (with a plant expansion but got hit with declining sales of the active ingredients) while developing IP to integrate these ingredients to move into value added cosmeceuticals and nutraceuticals.

An overview of their pipeline is given on their website.

ceapro.com

They recently won an award from their peers for their active raw material iBG (impregnated Beta Glucan with CoQ10 using their PGX technology) and embarked with the Montreal Heart Institute on clinical studies with a Beta Glucan pill to see its effectiveness as a cholesterol reducer.

stockhouse.com

stockhouse.com

After delays in meeting deadlines, Ceapro is on the brink of other deliverables (ie. functional drink, licensing of PGX technology) as well that should reward patient investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext